CRISPR Therapeutics AG (CRSP)

55.90 +1.17 (+2.14%) USD  |  NASDAQ  |  Jan 22, 09:44
More

CRISPR Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
BeOne Medicines Ltd. Upgrade